ID

12812

Beschreibung

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02010931

Link

https://clinicaltrials.gov/show/NCT02010931

Stichworte

  1. 21.12.15 21.12.15 -
Hochgeladen am

21. Dezember 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Lymphoblastic Leukemia NCT02010931

Eligibility Acute Lymphoblastic Leukemia NCT02010931

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission defined as less than 5 percent blasts in bone marrow after at least 3 intensive chemotherapy blocks (i.e. any standard or investigational regimen according to adult protocols as long as 3 age appropriate chemotherapy blocks were given, this also includes relapse treatment
Beschreibung

philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission

Datentyp

boolean

Alias
UMLS CUI [1]
C1960645
UMLS CUI [2]
C0457341
detection of minimal residual disease (molecular failure or molecular relapse) at a level of greater than or equal to 10*(-4) by pcr or greater than or equal to 10*(-3) by flow cytometry at a reference lab
Beschreibung

detection of minimal residual disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1511791
age 15 or greater at time of initial diagnosis with acute lymphoblastic leukemia. for patients aged 15-17 treatment according to adult protocols is required
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
initial diagnosis in the year 2000 or later
Beschreibung

initial diagnosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0011900
UMLS CUI [2]
C0332168
history of acute lymphoblastic leukemia treatment (including response to first therapy, number of prior relapses) is available
Beschreibung

patient medical history

Datentyp

boolean

Alias
UMLS CUI [1]
C0262926
relapse status and disease follow up after timepoint of minimal residual disease detection is available
Beschreibung

relapse status and disease follow up

Datentyp

boolean

Alias
UMLS CUI [1]
C1277192
UMLS CUI [2]
C0589120
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with extramedullary disease at timepoint of minimal residual disease detection
Beschreibung

extramedullary disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1868812
use of blinatumomab within 18 months of minimal residual disease detection
Beschreibung

blinatumomab

Datentyp

boolean

Alias
UMLS CUI [1]
C3853839
allogeneic hematopoietic stem cell transplantation prior to minimal residual disease detection at the required level
Beschreibung

allogeneic hematopoietic stem cell transplantation

Datentyp

boolean

Alias
UMLS CUI [1]
C2242529

Ähnliche Modelle

Eligibility Acute Lymphoblastic Leukemia NCT02010931

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission
Item
patients with philadelphia-negative b-precursor acute lyphmoblastic leukemia in complete hematological remission defined as less than 5 percent blasts in bone marrow after at least 3 intensive chemotherapy blocks (i.e. any standard or investigational regimen according to adult protocols as long as 3 age appropriate chemotherapy blocks were given, this also includes relapse treatment
boolean
C1960645 (UMLS CUI [1])
C0457341 (UMLS CUI [2])
detection of minimal residual disease
Item
detection of minimal residual disease (molecular failure or molecular relapse) at a level of greater than or equal to 10*(-4) by pcr or greater than or equal to 10*(-3) by flow cytometry at a reference lab
boolean
C1511791 (UMLS CUI [1])
age
Item
age 15 or greater at time of initial diagnosis with acute lymphoblastic leukemia. for patients aged 15-17 treatment according to adult protocols is required
boolean
C0001779 (UMLS CUI [1])
initial diagnosis
Item
initial diagnosis in the year 2000 or later
boolean
C0011900 (UMLS CUI [1])
C0332168 (UMLS CUI [2])
patient medical history
Item
history of acute lymphoblastic leukemia treatment (including response to first therapy, number of prior relapses) is available
boolean
C0262926 (UMLS CUI [1])
relapse status and disease follow up
Item
relapse status and disease follow up after timepoint of minimal residual disease detection is available
boolean
C1277192 (UMLS CUI [1])
C0589120 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
extramedullary disease
Item
patients with extramedullary disease at timepoint of minimal residual disease detection
boolean
C1868812 (UMLS CUI [1])
blinatumomab
Item
use of blinatumomab within 18 months of minimal residual disease detection
boolean
C3853839 (UMLS CUI [1])
allogeneic hematopoietic stem cell transplantation
Item
allogeneic hematopoietic stem cell transplantation prior to minimal residual disease detection at the required level
boolean
C2242529 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video